Early implementation of treatment with biologic or targeted synthetic DMARDs after methotrexate failure did not prevent the ...

Substantial improvements in ultrasound technology and expanded use of it have necessitated an update of the 2012 ...

Dr. Mark Hawass, the trailblazing founder of Arthritis VIP, has been honoured with an esteemed ‘Impact Award’ from Big ...

Miracles Healthcare combines a team of experienced specialists with the latest medical technology, ensuring that each patient ...

Founded with a mission to address the “last-mile” challenges in pain relief, Doloromics integrates artificial intelligence ...

Arthritis pain can be incredibly debilitating, impacting everyday tasks and overall quality of life. While many treatments ...

Joint pain, while common, shouldn't be ignored, especially when it becomes persistent. Although not all joint pain signals ...

Sixty-nine-year-old Mary Anne Laporte was diagnosed with knee arthritis 15 years ago. For years, she kept the pain under control with steroid injections and physical therapy, but when she began ...

Arthritis patients often struggle to get a good night's sleep due to pain and stiffness. Establishing a regular sleep ...

Raising care to the best standards of care could save billions of dollars and improve Americans' quality of life ...

The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.